Company Filing History:
1 out of 43 
1 out of 116 
Years Active: 2025
Title: Damian Wild: Innovator in Radiopeptide Technology
Introduction
Damian Wild is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of radiopeptides, particularly in the development of therapeutic agents for tumor diseases. His innovative work has led to the creation of a unique radiopeptide that holds promise for cancer treatment.
Latest Patents
Damian Wild holds a patent for a radiopeptide that comprises a radionuclide, specifically terbium-161, along with a chelator that coordinates this radionuclide and a peptide or peptide analogue that acts as a somatostatin receptor antagonist. This invention is designed to enhance treatment options for patients suffering from tumor diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Damian has worked with esteemed institutions such as Universität Basel and the Paul Scherrer Institut. His research has focused on the intersection of chemistry and medicine, leading to advancements in targeted therapies.
Collaborations
Damian has collaborated with notable colleagues, including Cristina Müller and Roger Schibli, who have contributed to his research endeavors and the development of his patented technologies.
Conclusion
Damian Wild's innovative work in radiopeptide technology exemplifies the potential of scientific research to address critical health challenges. His contributions are paving the way for new treatment modalities in oncology.